Cardiovascular Medicine (H.I., Y.N., H.K., K.M., H.Y., T. Nishikimi, T. Kimura), Graduate School of Medicine, Kyoto University.
Cardiovascular Medicine (K.K., M.O., H.M.), School of Medicine, Shinshu University, Matsumoto.
Circ Res. 2022 Jan 21;130(2):234-248. doi: 10.1161/CIRCRESAHA.121.318898. Epub 2021 Dec 8.
During the development of heart failure, a fetal cardiac gene program is reactivated and accelerates pathological cardiac remodeling. We previously reported that a transcriptional repressor, NRSF (neuron restrictive silencer factor), suppresses the fetal cardiac gene program, thereby maintaining cardiac integrity. The underlying molecular mechanisms remain to be determined, however.
We aim to elucidate molecular mechanisms by which NRSF maintains normal cardiac function. We generated cardiac-specific NRSF knockout mice and analyzed cardiac gene expression profiles in those mice and mice cardiac-specifically expressing a dominant-negative NRSF mutant.
We found that cardiac expression of Gα, an inhibitory G protein encoded in humans by , is transcriptionally regulated by NRSF and is increased in the ventricles of several mouse models of heart failure. Genetic knockdown of ameliorated the cardiac dysfunction and prolonged survival rates in these mouse heart failure models. Conversely, cardiac-specific overexpression of in mice was sufficient to induce cardiac dysfunction. Mechanistically, we observed that increasing Gα expression increased surface sarcolemmal L-type Ca channel activity, activated CaMKII (calcium/calmodulin-dependent kinase-II) signaling, and impaired Ca handling in ventricular myocytes, which led to cardiac dysfunction.
These findings shed light on a novel function of Gα in the regulation of cardiac Ca homeostasis and systolic function and suggest Gα may be an effective therapeutic target for the treatment of heart failure.
在心力衰竭的发展过程中,胎儿心脏基因程序被重新激活,从而加速病理性心脏重构。我们之前的研究报告表明,转录抑制因子 NRSF(神经元限制沉默因子)抑制胎儿心脏基因程序,从而维持心脏完整性。然而,其潜在的分子机制仍有待确定。
我们旨在阐明 NRSF 维持正常心脏功能的分子机制。我们生成了心脏特异性 NRSF 敲除小鼠,并分析了这些小鼠以及心脏特异性表达显性负性 NRSF 突变体的小鼠的心脏基因表达谱。
我们发现,人类基因编码的抑制性 G 蛋白 Gα在心脏中的表达受 NRSF 转录调控,并且在几种心力衰竭小鼠模型的心室中增加。在这些小鼠心力衰竭模型中,抑制 基因的表达可改善心脏功能障碍并延长生存率。相反,在小鼠中过表达心脏特异性 足以诱导心脏功能障碍。从机制上讲,我们观察到增加 Gα表达会增加肌膜表面 L 型 Ca 通道的活性,激活 CaMKII(钙/钙调蛋白依赖性激酶-II)信号,并损害心室肌细胞的 Ca 处理,从而导致心脏功能障碍。
这些发现揭示了 Gα在调节心脏 Ca 稳态和收缩功能中的新功能,并表明 Gα可能是心力衰竭治疗的有效治疗靶点。